Patents
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
12/1997
12/03/1997CN1036587C Process for preparation of cephalosporin antibiotic
12/03/1997CN1036569C Method of producing skin-rubbing agent for curing the dysentery and diarrhoed of domestic animals
12/02/1997US5693858 Organic salts of N,N'-diacetyl cystine
12/02/1997US5693857 Process and intermediate for the preparation of 2-hydroxy-3-sulfido-3-phenyl propanoic acids
12/02/1997US5693850 Nutritive water soluble glycerol esters of hydroxy butyric acid
12/02/1997US5693844 2-cyano-3-hydroxy-propenamides
12/02/1997US5693827 Treatment of HIV infections and compounds useful therein
12/02/1997US5693818 Process for preparing pure salts of pyridinylmethyl-sulfinyl-1H-benzimidazole
12/02/1997US5693814 Crystals of antimicrobial compound
12/02/1997US5693805 Sulfonamidation of chlorosulfonylcamphor with piperazine derivative salt, oximation, reduction, selective amidation of endo amine isomer, salt formation; tocolytic agents
12/02/1997US5693804 Substituted 1-aryl-3-piperazin-1'-yl propanones
12/02/1997US5693803 Epoxide intermediates formed by reacting amine nucleophile with activated glycidyl derivative
12/02/1997US5693800 N-(2-amino-4,6-dichloropyrimidine-5-yl) formamide and a process for its preparation
12/02/1997US5693795 Process for the manufacture of 4H-imidazo 1,5-A! 1,4!benzodiazepines
12/02/1997US5693790 Crystalline form of a cephalosporin antibiotic
12/02/1997US5693787 Stereospecific
12/02/1997US5693775 Fibroblast growth factor homologous factor-1 (FHF-1) and methods of use
12/02/1997US5693772 Desalaninebenanomicin A derivatives and processes for the preparation thereof
12/02/1997US5693769 Glycosylated steroid derivatives for transport across biological membranes and process for making and using same
12/02/1997US5693751 Water soluble high molecular weight polymerized drug preparation
12/02/1997US5693750 Microbiocidal action against pneumocystis infections
12/02/1997US5693676 Using nitroglycerin to treat anal fissures or ulcers, hemorrhoids, levator spasms
12/02/1997US5693675 Alkylated amine polymers
12/02/1997US5693674 Method of using triaryl-ethylene derivatives in the treatment and prevention of osteoporosis
12/02/1997US5693673 Process of preparing 2,2'-(1-methyl-1,2-ethanediylidene)bis hydrazine caroximidamide!
12/02/1997US5693672 3,4,5-substituted benzoylguanidines, process for their preparation, their use as a medicament or diagnostic and medicament containing them
12/02/1997US5693671 Isomer is administered orally
12/02/1997US5693670 Composition containing a dihydroxyacetone precursor
12/02/1997US5693669 Dissolving tilidine in mixture of isopropanol and water, mild heating and stirring while adding phosphoric acid, then cooling and crystallization yields stable tilidine dihydrogen orthophosphate
12/02/1997US5693667 Fungicides for the control of take-all disease of plants
12/02/1997US5693666 Used in treating mammalian tumors
12/02/1997US5693665 Alkylated (hetero) cyclic compounds
12/02/1997US5693664 Use of R-(+)-α-lipoic acid, R-(-)dihydrolipoic acid and metabolites in the form of the free acid or salts or esters or amides for the preparation of drugs for the treatment of diabetes mellitus as well as of its sequelae
12/02/1997US5693661 Viricides against rhinoviruses, picornaviruses
12/02/1997US5693657 Useful for treating hypercholesterolemia or atherosclerosis
12/02/1997US5693656 Methods for inhibiting endometriosis
12/02/1997US5693655 Substituted di-indolylpiperidines for treatment of nervous system disorders
12/02/1997US5693654 Medicaments for treating intraocular pressure
12/02/1997US5693653 Administering an antidepressants
12/02/1997US5693652 Benzimidazoles for ischemic heart conditions
12/02/1997US5693651 Quinoline derivatives
12/02/1997US5693650 4-(Quinolin-2-yl-methoxy)-phenyl-acetic acid derivatives
12/02/1997US5693649 N-substituted azaheterocyclic carboxylic acids and esters thereof
12/02/1997US5693645 Use of spiperone or spiperone derivatives as immunosuppressant agents
12/02/1997US5693642 Anxiolytic and hypotensive agents; antidepressants; psychological disorders; controllers of sleep/wake cycle, eating and sexual disorders
12/02/1997US5693641 Enzyme inhibitor treating blood disorder
12/02/1997US5693639 Therapeutic heterocyclyl amionosulfonyl phenyl compounds
12/02/1997US5693638 Method of treating a migraine headache
12/02/1997US5693637 Bicycle derivatives, their preparation and use
12/02/1997US5693636 Bicyclic fibrinogen antagonists
12/02/1997US5693634 For systemic and topical treatment of humans and animals; veterinary medicine
12/02/1997US5693633 Angiotensin II antagonists
12/02/1997US5693630 Phenylethyl and phenylpropylamines
12/02/1997US5693628 11-benzaldoxime-estra-diene derivatives, methods for their production and pharmaceuticals containing these compounds
12/02/1997US5693627 Use of phosphotyrosine phosphatase inhibitors for controlling cellular proliferation
12/02/1997US5693626 Treating or preventing fungal infections by oral or parenteral administration
12/02/1997US5693625 Administering dextran functionalized with carboxymethyl groups and benzylamide or benzylamide sulfonate groups to skin or cornea
12/02/1997US5693623 Topical preparations for the treatment of acne and acneiform dermatitis
12/02/1997US5693621 Inhibiting binding of selectin to carbohydrate ligands
12/02/1997US5693619 Method of using renin inhibiting N-(2-amino-2-oxoethyl) butanediamide derivatives
12/02/1997US5693617 Inhibitors of the 26s proteolytic complex and the 20s proteasome contained therein
12/02/1997US5693614 Drug for the treatment of senile dementia of the ischemic and hypoglycemic types
12/02/1997US5693530 Recombinant vectors; vaccines
12/02/1997US5693521 Membrane-permeant second messengers
12/02/1997US5693492 Purified dna molecule encoding drosophila avermectin and/or glutamate binding protein which functions as glutamate-gated anion channel
12/02/1997US5693335 Using a mixture of (1) a polyhydric thioalcohol having at least one mercapto and one hydroxy group and (2) a fatty acid or ester; transdermal patches; estrogen therapy
12/02/1997US5693321 Polymers containing diester units
12/02/1997US5693319 Polyamines and method for preparation thereof
12/02/1997US5693312 Pharmaceutical composition having analgesic activity
12/02/1997US5693311 Polyiodinated compounds, process for preparing them and diagnostic compositions
12/02/1997US5692302 Wound healing agent comprises pyruvic acid or salt, antioxidant, fatty acid mixture
12/02/1997CA2052679C Rotogranulations and taste masking coatings for preparation of chewable pharmaceutical tablets
12/02/1997CA2050639C Arylalkylamines, process for preparing them and pharmaceutical compositions containing them
12/02/1997CA2010011C N-phenyl-n-(4-piperidinyl) amides useful as analgesics
11/1997
11/30/1997CA2206469A1 Preparation of substituted alkenoic acids
11/30/1997CA2206466A1 Carbamoyl substituted heterocycles
11/30/1997CA2205770A1 Process for producing paroxetine
11/29/1997CA2206201A1 Pyrazole derivatives and their pharmaceutical use
11/29/1997CA2177553A1 Thiazolidinedione derivatives or salts thereof and pharmaceutical compositions containing the same
11/28/1997CA2206198A1 Bis-ortho-substituted benzoylguanidines, processes for their preparation, their use as a medicament or diagnostic, and medicament comprising them
11/27/1997WO1997044474A2 Viral particles which are masked or unmasked with respect to a cell receptor
11/27/1997WO1997044468A1 HUMAN INTERLEUKIN-1j AND ANTAGONISTS THEREOF
11/27/1997WO1997044461A2 Antigen binding fragments that specifically detect cancer cells, nucleotides encoding the fragments, and use thereof for the prophylaxis and detection of cancers
11/27/1997WO1997044460A1 Modulators of tissue regeneration
11/27/1997WO1997044454A2 Human phospholipase inhibitor
11/27/1997WO1997044453A1 Novel inhibitors of vascular endothelial growth factor activity, their uses and processes for their production
11/27/1997WO1997044441A1 New antigen presenting cells, a process for preparing the same and their use as cellular vaccines
11/27/1997WO1997044360A1 Novel human g-protein coupled receptor
11/27/1997WO1997044359A1 Novel human g-protein coupled receptor
11/27/1997WO1997044357A1 Synthetic glucagon binding proteins
11/27/1997WO1997044356A2 RET LIGAND (RetL) FOR STIMULATING NEURAL AND RENAL GROWTH
11/27/1997WO1997044354A2 Synthesis of soluble beta-sheet forming peptides
11/27/1997WO1997044352A1 Modulating the activity of hormones or their receptors - peptides, antibodies, vaccines and uses thereof
11/27/1997WO1997044350A1 Inhibitors of protein farnesyl transferase
11/27/1997WO1997044349A1 BLOCKING EXPRESSION OF VIRULENCE FACTORS IN $i(S. AUREUS)
11/27/1997WO1997044343A1 Phosphorus containing cythesine derivatives
11/27/1997WO1997044342A1 PROCESS FOR PREPARING 1-ARYL-4-OXOPYRROLO[3,2-c]QUINOLINE DERIVATIVES
11/27/1997WO1997044339A1 Antagonists of gonadotropin releasing hormone
11/27/1997WO1997044337A1 Benzofuran carboxamides and their therapeutic use
11/27/1997WO1997044336A1 Conjugates of cis-docosahexaenoic acid and paclitaxel